ARCH Technology for a Simple, Resilient, and Cost-Effective Auto- Injector
Award amount
$99,850Program and phase
SBIR · Phase IAward year
2013Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- AKTIVAX, INC.
- Proposal award date
- 2013-05-01
- Contract end date
- 2013-10-31
- UEI
- T1XHPCDJ4NT6
- Solicitation number
- 2013.1
- Topic code
- CBD13-106
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ARCH Technology for a Simple, Resilient, and Cost Effective Auto-Injector
- ARCH Technology for a Simple, Resilient, and Cost-Effective Auto- Injector
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A Miniature Autoinjector for Multicomponent Drugs and Vaccines
- Microfluidic Pneumatic Autoinjector Platform
- A Miniature Autoinjector for Multicomponent Drugs and Vaccines
Research funding history
3 SBIR/STTR records share this UEI (2013–2017). Reported award amounts total $1,652,098. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Defense